Φορτώνει......
‘Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut’
CD39 and CD73 control cell immunity by hydrolyzing proinflammatory ATP and ADP (CD39) into AMP, subsequently converted into anti-inflammatory adenosine (CD73). By regulating the balance between effector and regulatory cells, these ectonucleotidases promote immune homeostasis in acute and chronic inf...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biochem Pharmacol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8096647/ https://ncbi.nlm.nih.gov/pubmed/33460629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2021.114417 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|